Search for: "Paul Goldenheim"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
12 Dec 2011, 9:40 am
Former CEO Michael Friedman, general counsel Howard Udell and medical director Paul Goldenheim agreed in separate deals to give up $34.5 million in profits and to serve three years of probation. [read post]
6 Sep 2015, 8:26 am
Michael Friedman, the company's president, Howard Udell, Purdue's principal lawyer, and Paul Goldenheim, the company's former chief medical officer, will pay $634.5 million in fines for alleging that OxyContin had a lower incidence of abuse and addiction than the drug's competitors, according to United States Attorney John Brownlee. [read post]
27 Jul 2012, 12:36 pm
Friedman, Udell and Goldenheim appealed the U.S. [read post]
21 Jul 2007, 4:02 am
The company and its president Michael Friedman, who retired in June, its general counsel Howard Udell, and its former chief medical officer Paul Goldenheim plead guilty in May to a misdemeanor count of misbranding the drug for claiming that OxyContin was less addictive and less subject to abuse than other pain medications. [read post]
21 Jul 2007, 3:36 am
Michael Friedman, who retired in June as Purdue's president, general counsel Howard Udell and former chief medical officer Paul Goldenheim each pleaded guilty to a misdemeanor count of misbranding the drug. [read post]
10 Feb 2010, 12:49 am
Goldenheim -- caught up in the same scandal. [read post]
11 May 2007, 12:52 am
Company chief executive officer Michael Friedman, GC Howard Udell and former chief medical officer Paul Goldenheim each pleaded guilty to a misdemeanor count of misbranding the drug. [read post]
2 Aug 2012, 1:21 am
Under the Responsible Corporate Officer Doctrine, three Purdue executives – Purdue CEO Michael Friedman, general counsel Howard Udell, and medical director Paul Goldenheim—were accused of the misdemeanor of misbranding of a drug. [read post]
27 Jul 2012, 8:55 pm
Michael Friedman, Paul Goldenheim, and Howard Udell ("the Purdue Executives") were senior corporate officers at Purdue when the company marketed OxyContin. [read post]
